Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 39

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 39
---
 addition, certain of our officers are also engaged by third parties, including our Chief Financial Officer, which provides his services
to us through a third-party service firm. See “Management—Engagement Agreements with Executive Officers” for additional
information.

Despite our efforts to protect
our trade secrets and knowhow, our competitors may discover our trade secrets, either through breach of these agreements, independent
development or publication of information including our trade secrets by third parties. A competitor’s discovery of our trade secrets
and knowhow would impair our competitive position and have an adverse impact on our business, financial condition, results of operations
and prospects.

<div align='center'>29</div>

Risks Related to Our Intellectual Property

If we are unable to obtain significant patent protection for our products, or if our patents and other intellectual property rights do not adequately protect our products, we may be unable to gain significant market share and be unable to operate our business profitably.

We will rely on patents,
trade secrets, copyrights, know-how, trademarks, license agreements and contractual provisions to establish our intellectual property
rights and protect our products. These legal means, however, afford only limited protection and may not completely protect our rights.

As of September 29, 2025,
our exclusively owned patent portfolio includes thirty-four (34) issued patents, of which eight (8) are U.S. patents and twenty-six
(26) are foreign patents, with eighteen (18) of the twenty-six (26) foreign patents being nationally validated in certain European extension/validation
states). We cannot assure you that our intellectual property position will not be challenged or that all patents for which we have applied
will be granted. The validity and breadth of claims in patents involves complex legal and factual questions and, therefore, may be highly
uncertain. Uncertainties and risks that we face include the following:

| ● | our pending or future patent                                                                                               
 applications may not result in the issuance of patents;                                                                    |
| ● | the scope of any existing                                                                                                  
 or future patent protection may not exclude competitors or provide competitive advantages to us;                           |
| ● | our patents may not be                                                                                                     
 held valid or enforceable if subsequently challenged;                                                                      |
| ● | other parties may claim                                                                                                    
 that our products and designs infringe the proprietary rights of others—even if we are successful in defending our patents 
 and proprietary rights, the cost of such litigation may adversely affect our business; and                                 |
| ● | other parties may develop                                                                                                  
 similar